Reported Apr 10, 2013 · Terminated
Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited,…
Dr. Reddy'S Laboratories
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Dr. Reddy'S Laboratories · 200 Somerset Corporate Blvd FL 7 · Bridgewater, NJ · 08807-2862
Is this the product you have?
- Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle, Rx Only, Mfd
- By
Dr. Reddy's Laboratories LimitedBachepally - 500 090 IndiaNDC 55111-180-15
- Lot codes and dates
Lot #: C208625C208984C209113C209369Exp 09/15and C209680Exp 10/15
- Amount recalled
- 117,546 bottles
Where it was sold
- Nationwide
- PR
Why it was recalled
Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Dr. Reddy'S Laboratories recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.